New device-based technologies for aesthetic dermatology, including intense pulsed light (IPL) and lasers, are offering an innovative complement to traditional creams and make-up – bringing scientific innovation into skincare treatments and creating exciting market opportunities.
Used in conjunction with pre- and post-treatments, IPL and other technologies offer targeted solutions for a wide range of skin concerns such as sun damage, rosacea and acne, as well as skin rejuvenation and the reduction of age spots, helping to enhance overall skin tone.
However, these non-invasive, energy-based solutions are subject to close regulatory scrutiny, with safety and quality requirements that place significant obligations on both manufacturers and retailers. In such a technically focused field, what proactive strategies can support product development and market introduction while ensuring consumer trust and regulatory compliance?
This complimentary webinar provides an expert perspective on IPL and laser devices, as well as complementary pre- and post-care treatments. Practical insights into clinical testing and efficacy assessment will be provided, with an overview of the European regulatory landscape and clinical testing standards that govern the use of these devices. There will be a particular focus on the EU Medical Device Regulation (MDR) and the extended transitional provisions set out in Regulation (EU) 2023/607, which are key considerations for businesses operating in this space.
This webinar is aimed at manufacturers of energy-based devices, developers of cosmetics for pre- and post-treatments, regulatory professionals and clinical researchers.
This webinar takes place on February 24, 2026, at 4:00 PM (CET).
